High frequency mismatch repair (MMR) pathway mutations in adrenocortical carcinoma: Indication for routine MMR-deficiency (MMR-D) testing.

Akala, OO; Kelly, V; Strong, VE; Gopalan, A; Reidy, DL; Raj, NP

JOURNAL OF CLINICAL ONCOLOGY, 2018; 36 (15):